Details for New Drug Application (NDA): 022083
✉ Email this page to a colleague
The generic ingredient in EXELON is rivastigmine. There are thirty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the rivastigmine profile page.
Summary for 022083
Tradename: | EXELON |
Applicant: | Sandoz |
Ingredient: | rivastigmine |
Patents: | 0 |
Pharmacology for NDA: 022083
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 022083
Suppliers and Packaging for NDA: 022083
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083 | NDA | Novartis Pharmaceuticals Corporation | 0078-0501 | 0078-0501-15 | 30 PATCH in 1 CARTON (0078-0501-15) / 24 h in 1 PATCH (0078-0501-61) |
EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083 | NDA | Novartis Pharmaceuticals Corporation | 0078-0502 | 0078-0502-15 | 30 PATCH in 1 CARTON (0078-0502-15) / 24 h in 1 PATCH (0078-0502-61) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 4.6MG/24HR | ||||
Approval Date: | Jul 6, 2007 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 9.5MG/24HR | ||||
Approval Date: | Jul 6, 2007 | TE: | AB | RLD: | Yes |
Profile for product number 005
Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 13.3MG/24HR | ||||
Approval Date: | Aug 31, 2012 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 022083
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083-001 | Jul 6, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083-001 | Jul 6, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083-002 | Jul 6, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083-002 | Jul 6, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083-002 | Jul 6, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription